BAYNOVATION Trademark

Trademark Overview

On Monday, January 23, 2012, a trademark application was filed for BAYNOVATION with the United States Patent and Trademark Office. The USPTO has given the BAYNOVATION trademark a serial number of 85523148. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, August 12, 2013. This trademark is owned by NovaBay Pharmaceuticals, Inc.. The BAYNOVATION trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Scientific study in the field of medicine, namely, ophthalmology clinical studies on the efficacy and safety of a proprietary ophthalmic solution for the treatment of adenoviral conjunctivitis
baynovation

General Information

Serial Number85523148
Word MarkBAYNOVATION
Filing DateMonday, January 23, 2012
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, August 12, 2013
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 13, 2012

Trademark Statements

Goods and ServicesScientific study in the field of medicine, namely, ophthalmology clinical studies on the efficacy and safety of a proprietary ophthalmic solution for the treatment of adenoviral conjunctivitis
Pseudo MarkBAY NOVATION

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateSaturday, September 1, 2012
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameNovaBay Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressEmeryville, CA 94608
Party NameNovaBay Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressEmeryville, CA 94608

Trademark Events

Event DateEvent Description
Monday, August 12, 2013ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, August 12, 2013ABANDONMENT - NO USE STATEMENT FILED
Tuesday, January 8, 2013NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, November 13, 2012OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 13, 2012PUBLISHED FOR OPPOSITION
Wednesday, October 24, 2012NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, October 10, 2012LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, October 10, 2012ASSIGNED TO LIE
Tuesday, September 25, 2012APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, September 25, 2012TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, September 25, 2012CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, September 25, 2012TEAS RESPONSE TO OFFICE ACTION RECEIVED
Saturday, September 22, 2012NOTIFICATION OF NON-FINAL ACTION E-MAILED
Saturday, September 22, 2012NON-FINAL ACTION E-MAILED
Saturday, September 22, 2012NON-FINAL ACTION WRITTEN
Friday, August 31, 2012TEAS CHANGE OF CORRESPONDENCE RECEIVED
Saturday, September 1, 2012TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, August 31, 2012CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, August 31, 2012TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, May 7, 2012NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, May 7, 2012NON-FINAL ACTION E-MAILED
Monday, May 7, 2012NON-FINAL ACTION WRITTEN
Monday, April 30, 2012ASSIGNED TO EXAMINER
Friday, January 27, 2012NOTICE OF PSEUDO MARK MAILED
Thursday, January 26, 2012NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, January 26, 2012NEW APPLICATION ENTERED IN TRAM

Related Keywords

baynovation ophthalmic proprietary safety solution treatment conjunctivitis adenoviral efficacy studies field